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The Problem
• There are an estimated 25,000-30,000 people in Maine that
want treatment for OUD but do not have access1

• There are only 215-230 Suboxone providers in Maine, out
of approximately 2,000 PCPs1

• Only 30-35 PCP sites offer MAT out of approximately 5002
• Maine has very high opioid use rate: 60.4 pills per capita in
20142

• In 2016, Maine had 376 drug-induced deaths:3
• 84% caused by at least one opioid
• 38% increase from 2015

Source: Maine Attorney General
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Public Health Cost
• Nationwide, OUD related consequences have led to $56 billion in economic
costs4

• 2010 estimated cost of substance abuse in Maine was $1.4 billion5
• 2015 report showed Maine’s total health care cost from opioid abuse to be
$92,736,9666

• 4.15% of prescription pain medication is used non-medically, including
11.29% in the 18-25 demographic7
3

Community Perspective
• Perspectives from several local providers (MDs, NP):
•

“There is definitely a need, and we bear some of the responsibility for the problem. If there were support staff in place to
manage counseling, monitoring, urine drug screens etc. I would be more than willing to get waivered.”

•
•
•

“Time and access are problems- I already have a waiting list of patients.”
“I would need more education on how the process [Hub and Spoke] works”
“It’s slightly insulting that mid-level providers are required 3x more training to be waivered”

• Perspectives from meeting of Downeast Substance Treatment Group
•

“We have to help providers to be comfortable with Suboxone and with the system, so that when relapses happen they can be
comfortable that the Hub will be there to support them”

•

“The Suboxone waiver training was actually inspirational and encouraging – I wish there was a way to incentivize the training
as all my concerns were addressed during it”
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Intervention and Methodology
• Reviewed current situation regarding Suboxone prescribing in state of Maine
• Discussed with several community providers (MDs, NPs) their perspective
on barriers that exist to becoming waivered to prescribe Suboxone

• Created one page pamphlet including information on:
• State of the problem and need for MAT
• Information on Hub-and-Spoke model
• Process for becoming waivered
5

Hub and Spoke Model of Care
Information for Providers
Problem in Maine:
• There is a major need for providers in Maine that can prescribe buprenorphine, morphine
for Medication Assisted Treatment (MAT) for Opioid Use Disorder (OUD).
• It is estimated that 25,000-30,000 people in Maine want treatment for OUD but do not
have access1
• There are only 215-230 Suboxone providers in Maine, out of approximately 2,000 PCPs1
• In 2016, Maine had 376 drug-induced deaths:2
o 84% caused by at least one opioid
o 38% increase from 2015

Results- Handout

Hub-and-Spoke Model:3
The Hub-and-Spoke model for MAT was created to bring treating patients for addiction
disorders in line with the treatment for many other disease processes. Much like primary care
offices work together with cardiologists to manage patients with CHF or atrial fibrillation, Huband-Spoke allows local providers (spokes) to treat patients that are stable while having back-up
and support from addiction specialists at the hubs.
Hubs:
• Staffed by psychiatrist available for consultation
• Assess patients medical and psychiatric needs at intake, determine appropriate treatment
placement
• Bidirectional transfer to spokes
Spokes:
• For patients that have been deemed stabilized on MAT at the hub
• Local providers – family practitioners, internists, psychiatrists, obstetricians, pediatricians
• Direct access to hubs for consultations
• Supported by MAT team- 1 RN and behavioral health provider per 100 Medicaid patients
Process:
There are many different options available for online training to receive the waiver to prescribe
Suboxone. The requirement is one 8-hour course for MDs/DOs, and one 24-hour course for
NPs/PAs. See below for several options:
• American Society of Addiction Medicine
o Apply online: http://buprenorphine.samhsa.gov/forms/select-practitioner-type.php
o Mobile App: http://store.samhsa.gov/apps/mat/
o Resources: https://www.asam.org/education/live-online-cme/buprenorphinecourse/content-handouts
• Providers’ Clinical Support System for Medication Assisted Treatment
o Apply online: http://pcssmat.org/education-training/mat-waiver-training/
o Free training for MDs/DOs/NPs/PAs
o Offers many other CME courses, webinars, mentorship for MAT
• American Academy of Addiction Psychiatry
o Apply online: http://www.aaap.org/education-training/buprenorphine/
o $124 for members, $196 for non-members
1.
2.
3.

http://www.pressherald.com/2017/01/08/hurdles-dissuade-doctors-from-providing-suboxone/
Maine
Attorney
Generals
Office.
Expanded
Maine
Drug
Death
Report
for
2016.
http://www.maine.gov/ag/news/article.shtml?id=741243. Accessed May 2017.
Brooklyn, J.R., and Sigmon, S.C. (2017). Vermont Hub-and-Spoke Model of Care For Opioid Use Disorder: Development,
Implementation, and Impact. J Addict Med. 00(00), 1-7. DOI: 10.1097/ADM.0000000000000310.
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Evaluation of Effectiveness/Limitations
• This pamphlet was meant to be an educational/informational source for providers considering obtaining
waivers for prescription of Suboxone.

• It was well received by the leaders of the Downeast Substance Treatment Group and Maine Coast Memorial
Hospital associated PCPs at their weekly meeting

• Evaluating effectiveness of pamphlet could include:
•

Monitoring what clinics receive pamphlet and how rates of obtaining Suboxone waiver compare to clinics that do not receive
pamphlet

•

The overall goal is to increase the number of Suboxone providers in this region, so seeing an actual increase would be a good
measure of effectiveness

• Limitations include:
•
•

Only addressing the process of getting waivered, there is need for education on how the entire program works
Currently only in paper form- having electronic version will allow providers to click links to directly access training sites
7

Recommendations for Future Projects
• Future projects could delve into other barriers identified by providers
including:
• Need for support staff
• Education on Hub-and-Spoke model

• There will also certainly be challenges that come up during implementation
of Hub and Spoke in Maine that will need to be addressed, including:
• Patient access to counseling
• Patient awareness of program
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